• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素-蛋白酶体系统是SUMO-2/3循环的关键组成部分。

The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.

作者信息

Schimmel Joost, Larsen Katja M, Matic Ivan, van Hagen Martijn, Cox Jürgen, Mann Matthias, Andersen Jens S, Vertegaal Alfred C O

机构信息

Department of Molecular Cell Biology, Leiden University Medical Center, 2300 RC Leiden, the Netherlands.

出版信息

Mol Cell Proteomics. 2008 Nov;7(11):2107-22. doi: 10.1074/mcp.M800025-MCP200. Epub 2008 Jun 18.

DOI:10.1074/mcp.M800025-MCP200
PMID:18565875
Abstract

Many proteins are regulated by a variety of post-translational modifications, and orchestration of these modifications is frequently required for full control of activity. Currently little is known about the combinatorial activity of different post-translational modifications. Here we show that extensive cross-talk exists between sumoylation and ubiquitination. We found that a subset of SUMO-2-conjugated proteins is subsequently ubiquitinated and degraded by the proteasome. In a screen for preferential SUMO-1 or SUMO-2 target proteins, we found that ubiquitin accumulated in purified SUMO-2 conjugates but not in SUMO-1 conjugates. Upon inhibition of the proteasome, the amount of ubiquitin in purified SUMO-2 conjugates increased. In addition, we found that endogenous SUMO-2/3 conjugates, but not endogenous SUMO-1 conjugates, accumulated in response to proteasome inhibitors. Quantitative proteomics experiments enabled the identification of 73 SUMO-2-conjugated proteins that accumulated in cells treated with proteasome inhibitors. Cross-talk between SUMO-2/3 and the ubiquitin-proteasome system controls many target proteins that regulate all aspects of nucleic acid metabolism. Surprisingly the relative abundance of 40 SUMO-2-conjugated proteins was reduced by proteasome inhibitors possibly because of a lack of recycled SUMO-2. We conclude that SUMO-2/3 conjugation and the ubiquitin-proteasome system are tightly integrated and act in a cooperative manner.

摘要

许多蛋白质受多种翻译后修饰的调控,而充分控制其活性通常需要这些修饰的协同作用。目前,对于不同翻译后修饰的组合活性了解甚少。在此,我们表明SUMO化和泛素化之间存在广泛的相互作用。我们发现,一部分与SUMO-2结合的蛋白质随后会被泛素化,并被蛋白酶体降解。在筛选优先与SUMO-1或SUMO-2结合的靶蛋白时,我们发现泛素在纯化的SUMO-2结合物中积累,而在SUMO-1结合物中则没有。在蛋白酶体受到抑制后,纯化的SUMO-2结合物中泛素的含量增加。此外,我们发现内源性SUMO-2/3结合物,而非内源性SUMO-1结合物,会因蛋白酶体抑制剂而积累。定量蛋白质组学实验能够鉴定出73种在蛋白酶体抑制剂处理的细胞中积累的与SUMO-2结合的蛋白质。SUMO-2/3与泛素-蛋白酶体系统之间的相互作用控制着许多调节核酸代谢各个方面的靶蛋白。令人惊讶的是,蛋白酶体抑制剂使40种与SUMO-2结合的蛋白质的相对丰度降低,这可能是由于缺乏循环利用的SUMO-2所致。我们得出结论,SUMO-2/3结合与泛素-蛋白酶体系统紧密整合,并以协同方式发挥作用。

相似文献

1
The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.泛素-蛋白酶体系统是SUMO-2/3循环的关键组成部分。
Mol Cell Proteomics. 2008 Nov;7(11):2107-22. doi: 10.1074/mcp.M800025-MCP200. Epub 2008 Jun 18.
2
Comparison of the SUMO1 and ubiquitin conjugation pathways during the inhibition of proteasome activity with evidence of SUMO1 recycling.蛋白酶体活性抑制过程中SUMO1与泛素缀合途径的比较及SUMO1循环利用的证据
Biochem J. 2005 Dec 1;392(Pt 2):271-81. doi: 10.1042/BJ20050873.
3
SUMO-2/3 conjugates accumulating under heat shock or MG132 treatment result largely from new protein synthesis.在热休克或MG132处理下积累的SUMO-2/3缀合物主要来自新的蛋白质合成。
Biochim Biophys Acta. 2012 Apr;1823(4):911-9. doi: 10.1016/j.bbamcr.2012.01.010. Epub 2012 Jan 28.
4
The ubiquitin-like modifier FAT10 interferes with SUMO activation.泛素样修饰物 FAT10 干扰 SUMO 的激活。
Nat Commun. 2019 Oct 1;10(1):4452. doi: 10.1038/s41467-019-12430-z.
5
c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.c-Myc以一种依赖于SUMO化的方式靶向蛋白酶体进行降解,这一过程受PIAS1、SENP7和RNF4调控。
Cell Cycle. 2015;14(12):1859-72. doi: 10.1080/15384101.2015.1040965.
6
Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.核仁 SUMO-1 靶蛋白在蛋白酶体抑制后的蛋白质组学分析。
Mol Cell Proteomics. 2009 Oct;8(10):2243-55. doi: 10.1074/mcp.M900079-MCP200. Epub 2009 Jul 12.
7
Identification and Characterization of SUMO-SIM Interactions.小泛素样修饰蛋白特异性相互作用基序相互作用的鉴定与表征
Methods Mol Biol. 2016;1475:79-98. doi: 10.1007/978-1-4939-6358-4_6.
8
Converging Small Ubiquitin-like Modifier (SUMO) and Ubiquitin Signaling: Improved Methodology Identifies Co-modified Target Proteins.汇聚的小泛素样修饰物(SUMO)和泛素信号:改进的方法学可鉴定共修饰靶蛋白。
Mol Cell Proteomics. 2017 Dec;16(12):2281-2295. doi: 10.1074/mcp.TIR117.000152. Epub 2017 Sep 26.
9
Ubiquitin-dependent proteolytic control of SUMO conjugates.SUMO 缀合物的泛素依赖性蛋白水解控制
J Biol Chem. 2007 Nov 23;282(47):34167-75. doi: 10.1074/jbc.M706505200. Epub 2007 Aug 29.
10
A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.一种用于研究旁系特异性SUMO缀合的荧光体外测定法。
Methods Mol Biol. 2016;1475:67-78. doi: 10.1007/978-1-4939-6358-4_5.

引用本文的文献

1
METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma.METTL16-SENP3-LTF 轴赋予肝癌细胞对铁死亡的抗性并促进肿瘤发生。
J Hematol Oncol. 2024 Sep 2;17(1):78. doi: 10.1186/s13045-024-01599-6.
2
SUMOylation controls Hu antigen R posttranscriptional activity in liver cancer.SUMOylation 控制肝癌中 Hu 抗原 R 的转录后活性。
Cell Rep. 2024 Mar 26;43(3):113924. doi: 10.1016/j.celrep.2024.113924. Epub 2024 Mar 18.
3
SUMOylation modulates eIF5A activities in both yeast and pancreatic ductal adenocarcinoma cells.
SUMO化修饰在酵母细胞和胰腺导管腺癌细胞中均能调节真核翻译起始因子5A(eIF5A)的活性。
Cell Mol Biol Lett. 2024 Jan 16;29(1):15. doi: 10.1186/s11658-024-00533-5.
4
Paralogue-Specific Roles of SUMO1 and SUMO2/3 in Protein Quality Control and Associated Diseases.SUMO1 和 SUMO2/3 在蛋白质质量控制及相关疾病中的旁系同源物特异性作用。
Cells. 2023 Dec 20;13(1):8. doi: 10.3390/cells13010008.
5
MAP kinase ERK5 modulates cancer cell sensitivity to extrinsic apoptosis induced by death-receptor agonists.MAP 激酶 ERK5 调节癌细胞对外源凋亡的敏感性,这种凋亡是由死亡受体激动剂诱导的。
Cell Death Dis. 2023 Nov 2;14(11):715. doi: 10.1038/s41419-023-06229-6.
6
Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research.脆性X相关震颤/共济失调综合征中SUMO2/3表达水平与自噬过程的探索:解决研究局限性及对未来研究的见解
Cells. 2023 Sep 26;12(19):2364. doi: 10.3390/cells12192364.
7
The SUMOylation and ubiquitination crosstalk in cancer.癌症中的类泛素化修饰与泛素化修饰之间的相互作用
J Cancer Res Clin Oncol. 2023 Nov;149(17):16123-16146. doi: 10.1007/s00432-023-05310-z. Epub 2023 Aug 28.
8
SUMO-activated target traps (SATTs) enable the identification of a comprehensive E3-specific SUMO proteome.SUMO 激活靶标陷阱(SATTs)可用于鉴定全面的 E3 特异性 SUMO 蛋白酶体。
Sci Adv. 2023 Aug 2;9(31):eadh2073. doi: 10.1126/sciadv.adh2073.
9
Beyond metabolic waste: lysine lactylation and its potential roles in cancer progression and cell fate determination.超越代谢废物:赖氨酸酰化及其在癌症进展和细胞命运决定中的潜在作用。
Cell Oncol (Dordr). 2023 Jun;46(3):465-480. doi: 10.1007/s13402-023-00775-z. Epub 2023 Jan 19.
10
SUMO enhances unfolding of SUMO-polyubiquitin-modified substrates by the Ufd1/Npl4/Cdc48 complex.SUMO 增强 Ufd1/Npl4/Cdc48 复合物对 SUMO-多泛素化修饰底物的展开。
Proc Natl Acad Sci U S A. 2023 Jan 3;120(1):e2213703120. doi: 10.1073/pnas.2213703120. Epub 2022 Dec 27.